Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?

The daily RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.

Shares of these 4 pharma companies namely - Glenmark Pharma, Gland Pharma, Biocon and Laurus Labs have zoomed up to 79 per cent since the start of the March 2025 - thus outperforming the benchmark Nifty and the sectoral index by a wide margin, in spite of the US pharma tariff-related uncertainties.  In comparison, the NSE Nifty 50 index has gained 15.7 per cent, and the Nifty Pharma index has surged 15 per cent in the same period.  Following the sharp rally in the last five months, technical charts now show that these 4 pharma stocks are trading